Hyaluronic Acid Prevent Further Cartilage Damage of Osteoarthritis Based on Expression of Collagen Type II and Collagen Type X
DOI:
https://doi.org/10.3889/oamjms.2022.8748Keywords:
Knee osteoarthritis, Hyaluronic acid, Type II collagen, Type X collagenAbstract
Abstract
Objective: Osteoarthritis (OA) is a degenerative joint disease characterized by changes in the structure of the subchondral articular cartilage. Chondrocytes are responsible for the synthesis and integrity of the extracellular matrix of articular cartilage. Hyaluronic acid (HA) is believed to have a potential protective effect on joint cartilage through chondroprotective.
Materials and methods: This study is experimental research (pre and post-test control group design) with 20 samples divided into five groups, each consisting of four samples. Four different dosages of HA have been given to the treatment group: 0.1 mg/ml, 1 mg/ml, 2 mg/ml, and 3 mg/ml. Subsequently, collagen type II (COL2) and type X (COL10) were examined using the ELISA method, and data were analyzed with SPSS 20.0
Result: Our study revealed that COL2 expression was not significantly different between the control group and 0.1 mg/ml. Interestingly, with 1 mg/ml of HA, there was a markedly significant increase in the expression of COL2 (p < 0,05), and a further increase in dosage did not give an incremental effect. Conversely, treatment of HA significantly suppressed the expression of COL10, but no enhanced suppression was found with increasing dose.
Conclusion: The administration of HA results in an increased number of COL2 and reduced number of COL10 and has the potential function of inhibiting the degeneration process in joint cartilage.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323-30. https://doi.org/10.1136/annrheumdis-2013-204763 PMid:24553908 DOI: https://doi.org/10.1136/annrheumdis-2013-204763
Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H, et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017;114(35):9332-6. https://doi.org/10.1073/pnas.1703856114 PMid:28808025 DOI: https://doi.org/10.1073/pnas.1703856114
Arden N, Nevitt MC. Osteoarthritis: Epidemiology. Best Pract Res. 2006;20(1):3-25. https://doi.org/10.1016/j.berh.2005.09.007 PMid:16483904 DOI: https://doi.org/10.1016/j.berh.2005.09.007
Van der Kraan PM, Van den Berg WB. Chondrocyte hypertrophy and osteoarthritis: Role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage. 2012;20(3):223-32. https://doi.org/10.1016/j.joca.2011.12.003 PMid:22178514 DOI: https://doi.org/10.1016/j.joca.2011.12.003
Maxwell NJ, Ryan MB, Taunton JE, Gillies JH, Wong AD. Sonographically guided intratendinous injection of hyperosmolar dextrose to treat chronic tendinosis of the Achilles tendon: A pilot study. AJR Am J Roentgenol. 2007;189(4):215-20. https://doi.org/10.2214/AJR.06.1158 PMid:17885034 DOI: https://doi.org/10.2214/AJR.06.1158
Shakibaei M, Allaway D, Nebrich S, Mobasheri A. Botanical extracts from rosehip (Rosa canina), willow bark (Salix alba), and nettle leaf (Urtica dioica) suppress IL-1β-induced NF-κB activation in canine articular chondrocytes. Evid Based Complement Alternat Med. 2012;2012:509383. https://doi.org/10.1155/2012/509383 PMid:22474508 DOI: https://doi.org/10.1155/2012/509383
Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review. BMC Musculoskelet Disord. 2015;16(1):321. https://doi.org/10.1186/s12891-015-0775-z PMid:26503103 DOI: https://doi.org/10.1186/s12891-015-0775-z
Monfort J, Pelletier JP, Garcia-Giralt N, Martel-Pelletier J. Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. Ann Rheum Dis. 2008;67(6):735-40. https://doi.org/10.1136/ard.2006.068882 PMid:17644553 DOI: https://doi.org/10.1136/ard.2006.068882
Galli M, De Santis V, Tafuro L. Reliability of the ahlbaäck classification of knee osteoarthritis. Osteoarthritis Cartilage. 2003;11(8):580-4. https://doi.org/10.1016/s1063-4584(03)00095-5 PMid:12880580 DOI: https://doi.org/10.1016/S1063-4584(03)00095-5
Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-89. https://doi.org/10.1016/j.joca.2019.06.011 PMid:31278997 DOI: https://doi.org/10.1016/j.joca.2019.06.011
de l’Escalopier N, Anract P, Biau D. Surgical treatments for osteoarthritis. Ann Phys Rehabil Med. 2016;59(3):227-33. https://doi.org/10.1016/j.rehab.2016.04.003 PMid:27185463 DOI: https://doi.org/10.1016/j.rehab.2016.04.003
Fernández S, Córdoba M. Hyaluronic acid as capacitation inductor: Metabolic changes and membrane-associated adenylate cyclase regulation. Reprod Domest Anim Zuchthyg. 2014;49(6):941-6. https://doi.org/10.1111/rda.12410 PMid:25251082 DOI: https://doi.org/10.1111/rda.12410
Lian C, Wang X, Qiu X, Wu Z, Gao B, Liu L, et al. Collagen Type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1-SMAD1 interaction. Bone Res. 2019;7(1):8. https://doi.org/10.1038/s41413-019-0046-y PMid:30854241 DOI: https://doi.org/10.1038/s41413-019-0046-y
Allemann F, Mizuno S, Eid K, Yates KE, Zaleske D, Glowacki J. Effects of hyaluronan on engineered articular cartilage extracellular matrix gene expression in 3-dimensional collagen scaffolds. J Biomed Mater Res. 2001;55(1):13-9. https://doi.org/10.1002/1097-4636(200104)55::1<13:aid-jbm20>3.0.co;2-g PMid:11426390 DOI: https://doi.org/10.1002/1097-4636(200104)55:1<13::AID-JBM20>3.0.CO;2-G
Zheng Q, Zhou G, Morello R, Chen Y, Garcia-Rojas X, Lee B. Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo. J Cell Biol. 2003;162(5):833-42. https://doi.org/10.1083/jcb.200211089 PMid:12952936 DOI: https://doi.org/10.1083/jcb.200211089
He Y, Manon-Jensen T, Arendt-Nielsen L, Petersen KK, Christiansen T, Samuels J, et al. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis. Osteoarthritis Cartilage. 2019;27(4):611-20. https://doi.org/10.1016/j.joca.2019.01.001 PMid:30654118 DOI: https://doi.org/10.1016/j.joca.2019.01.001
He Y, Siebuhr AS, Brandt-Hansen NU, Wang J, Su D, Zheng Q, et al. Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation. BMC Musculoskelet Disord. 2014;15(1):309. https://doi.org/10.1186/1471-2474-15-309 PMid:25245039 DOI: https://doi.org/10.1186/1471-2474-15-309
Amann E, Wolff P, Breel E, van Griensven M, Balmayor ER. Hyaluronic acid facilitates chondrogenesis and matrix deposition of human adipose derived mesenchymal stem cells and human chondrocytes co-cultures. Acta Biomater. 2017;52:130-44. https://doi.org/10.1016/j.actbio.2017.01.064 PMid:28131943 DOI: https://doi.org/10.1016/j.actbio.2017.01.064
Girotto D, Urbani S, Brun P, Renier D, Barbucci R, Abatangelo G. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials. 2003;24(19):3265-75. https://doi.org/10.1016/s0142-9612(03)00160-1 PMid:12763454 DOI: https://doi.org/10.1016/S0142-9612(03)00160-1
Downloads
Published
How to Cite
License
Copyright (c) 2022 Mohamad Hidayat, Krisna Yuarno Phatama, Tofan Margaret Dwi Saputra, Domy Pradana Putra, Lasa Dhakka Siahaan, Muhammad Alwy Sugiarto, Ananto Satya Pradana, Edi Mustamsir (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
